NCT05647590View on ClinicalTrials.gov

SBRT/RT in Oligometastatic Stage IV NSCLC

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Non Small Cell Lung Cancer
Interventions
PROCEDURE

Chemotherapy

3 months of platinum doublet chemotherapy (cDDP / CBDCA + Pemetrexed, NVB)

PROCEDURE

Radiotherapy (RT) + Stereotactic Body Ratio Therapy (SBRT)

"* RT to primary tumor + SBRT to all oligometa (max. 10 intra / extracranial lesions, intracranial SD / PR)~* SBRT V \< 100 ml, if technically possible fractionation RT (40 - 50 Gy / 16 - 20 fractions), SBRT (30 Gy / 1 fraction, 50 - 60 Gy / 3 - 5 fractions) 3 - 6 weeks … maintenance"

PROCEDURE

Maintenance chemotherapy

Maintenance chemotherapy will follow 3-6 weeks after RT.

Trial Locations (1)

708 52

RECRUITING

University Hospital Ostrava, Ostrava

All Listed Sponsors
lead

University Hospital Ostrava

OTHER